ABVC BioPharma Inc

ABVCNASDAQ · USD
1.16USD0.00 (+0.87%)
112

ABVC BioPharma Inc (ABVC) Straddle

No qualifying straddle setups were found for ABVC in the prior session.

Read more

Trading a ABVC straddle lets you take a pure volatility position on ABVC BioPharma Inc without committing to a direction. ABVC BioPharma Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate ABVC straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on ABVC profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when ABVC BioPharma Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the ABVC straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage.

It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the ABVC straddle is the cleanest expression of that view. Our scanner prices every ABVC straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a ABVC straddle into a catalyst or short a ABVC straddle to harvest decay, the options straddle setups that matter are all in one place.

No illustrative rows to display.

As of September 18, 2026

Find the right straddle before volatility moves

Track ABVC straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial